Viral vaccines for bony fish: Past, present and future

Expert Review of Vaccines

Volumn 12, Issue 5, 2013, Pages 567-578

  Salgado Miranda, Celene ^a   Loza Rubio, Elizabeth ^b   Rojas Anaya, Edith ^b   García Espinosa, Gary ^c  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE INVESTIGACIONES FORESTALES   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

attenuated vaccines; bony fish; DNA vaccines; inactivated vaccines; recombinant vaccines; viral vaccines

Indexed keywords

ALUMINUM PHOSPHATE; DNA VACCINE; INACTIVATED VIRUS VACCINE; PEPTIDE VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

AEROMONAS PUNCTATA; ANTIGEN PRESENTING CELL; AQUACULTURE; ATLANTIC SALMON; DISEASE SEVERITY; ENVIRONMENTAL IMPACT; EPIZOOTIC HEMATOPOIETIC NECROSIS; EPIZOOTIC ULCERATIVE SYNDROME; EXOPHTHALMOS; FINGERLING; FISH DISEASE; GENOTYPE; GRANULOMATOUS INFLAMMATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTIOUS PANCREATIC NECROSIS; INFECTIOUS SALMON ANEMIA; INNATE IMMUNITY; KIDNEY NECROSIS; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAINBOW TROUT; REOVIRUS; REVIEW; SALMONID; SEROTYPE; VACCINATION; VIRAL HEMORRHAGIC SEPTICEMIA; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS TRANSMISSION;

ANIMALS; AQUACULTURE; CYPRINIDAE; DRUG DISCOVERY; FISH DISEASES; SALMONIDAE; VACCINES, DNA; VACCINES, INACTIVATED; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUS DISEASES;

EID: 84877612777     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.13.38     Document Type: Review

References (114)

1. Food and Agriculture Organization of the United Nations. The State of the World Fisheries and Aquaculture. FAO, Italy (2012).
2. Crane M, Hyatt A. Viruses of fish: an overview of significant pathogens. Viruses 3(11), 2025-2046 (2011).
3. Asche F, Hansen H, Tveteras R, Tveteras S. The salmon disease crisis in Chile. Mar. Resour. Econ. 24(4), 405-411 (2009).
4. Ortega SC, Montes de Oca R, Groman D, Yason C, Nicholson B, Blake S. Case report: viral infectious pancreatic necrosis in farmed rainbow trout from Mexico. J. Aquat. Anim. Health 14(4), 305-310 (2002).
5. Ortega SC, Vega F, Enríquez R. Occurrence of the infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss) farms in Hidalgo State, Mexico. Bulletin Eur. Assoc. Fish Pathologists 27(3), 100-107 (2007).
6. Salgado-Miranda C, Corona-Barrera E, Marín A, et al. Prevalence of infectious pancreatic necrosis virus from rainbow trout (Oncorhynchus mykiss) farms in Mexico. Presented at: 13th International Conference of the European Association of Fish Pathologists. Grado, Italy, 17-21 September 2007.
7. Salgado-Miranda C, Corona-Barrera E, Marín GRA, et al. Prevalence and distribution of infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss) from commercial farms in Mexico. Presented at: World Aquaculture 2009. Veracruz, Mexico, 25-29 September 2009.
8. Gomez-Casado E, Estepa A, Coll JM. A comparative review on European-farmed finfish RNA viruses and their vaccines. Vaccine 29(15), 2657-2671 (2011).
9. Grisez L, Tan Z. Vaccine development for Asian aquaculture. In: Diseases in Asian Aquaculture V. Walker P, Lester R, Bondad-Reantaso MG (Eds). Fish Health Section, Asian Fisheries Society, Manila, 483-494 (2005).
10. Sahoo PK, Goodwin AE. Viruses of freshwater finfish in the Asian-Pacific region. Indian J. Virol. 23(2), 99-105 (2012).
11. Chinchar VG, Hyatt A, Miyazaki T, Williams T. Family Iridoviridae: poor viral relations no longer. Curr. Top. Microbiol. Immunol. 328, 123-170 (2009).
12. OIE (World Organization for Animal Health). Manual of Diagnostic Tests for Aquatic Animals 2003 (4th Edition). Organisation Mondiale de la Santé Animale, France (2003).
13. Bravo S, Midtlyng PJ. The use of fish vaccines in the Chilean salmon industry 1999-2003. Aquaculture 270(1-4), 36-42 (2007).
14. Enright WJ. Focus: fish health. Intrafish 1(2), 12-19 (2003).
15. Walker PJ, Winton Jr. Emerging viral diseases of fish and shrimp. Vet. Res. 41(6),(2010).
16. Vendramin N, Patarnello P, Toffan A, et al. Viral encephalopathy and retinopathy in groupers (Epinephelus spp.) in southern Italy: a threat for wild endangered species? BMC Vet. Res. 9, 20 (2013).
17. OIE (World Organisation for Animal Health). Manual of Diagnostic Tests for Aquatic Animals 2012 (7th Edition). Organisation Mondiale de la Santé Animale, France (2012).
18. Taksdal T, Olsen AB, Bjerkås I, et al. Pancreas disease in farmed Atlantic salmon, Salmo salar L., and rainbow trout, Oncorhynchus mykiss (Walbaum), in Norway. J. Fish Dis. 30(9), 545-558 (2007).
19. He Y, Xu H, Yang Q, Xu D, Lu L. The use of an in vitro microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against grass carp reovirus. Virol. J. 22(8), 132 (2011).
20. Rangel AA, Rockemann DD, Hetrick FM, Samal SK. Identification of grass carp haemorrhage virus as a new genogroup of aquareovirus. J. Gen. Virol. 80 (Pt 9), 2399-2402 (1999).
21. Yoshimizu M. Control strategy for viral disease of salmonid fish, flounders and shrimp at hatchery and seed production facility in Japan. Fish Pathol. 44(1), 9-13 (2009).
22. Plant KP, Lapatra SE. Advances in fish vaccine delivery. Dev. Comp. Immunol. 35(12), 1256-1262 (2011).
23. LaPatra S. Current trends in immunotherapy and vaccine development for viral disease of fish. In: Current Trends in the Study of Bacterial and Viral Fish and Shrimp Diseases. Leung KY (Ed.). World Scientific Publishing Co. Pte. Ltd, Singapore 363-389 (2004).
24. Kurath G. Biotechnology and DNA vaccines for aquatic animals. Rev. Off. Int. Epizoot. 27(1), 175-196 (2008).
25. Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev. Off. Int. Epizoot. 26(1), 29-48 (2007).
26. Van Muiswinkel WB. A history of fish immunology and vaccination I. The early days. Fish Shellfish Immunol. 25(4), 397-408 (2008).
27. Duff DCB. The oral immunization of trout against Bacterium salmonicida. J. Immunol. 44(1), 87-94 (1942).
28. Evelyn TP. A historical review of fish vaccinology. Dev. Biol. Stand. 90, 3-12 (1997).
29. Håstein T, Gudding R, Evensen O. Bacterial vaccines for fish-an update of the current situation worldwide. Dev. Biol. (Basel) 121, 55-74 (2005).
30. Mitchell H. Choosing a furunculosis vaccine: points to consider. Bull. Aquacult. Assoc. Can. 95(3), 30-37 (1995).
31. Horne MT. Technical aspects of the administration of vaccines. Dev. Biol. Stand. 90, 79-89 (1997).
32. Fryer JL, Rohovec JS, Tebbit GL, McMichael JS, Pilcher KS. Vaccination for control of infectious diseases in pacific salmon. Fish Pathol. 10(2), 155-164 (1976).
33. Dorson M, Castric J, Torchy C. Infectious pancreatic necrosis virus of salmonids: biological and antigenic features of a pathogenic strain and non-pathogenic variant selected in RTG-2 cells. J. Fish Dis. 1(4), 309-320 (1978).
34. Leong JC, Fryer JL. Viral vaccines for aquaculture. Annu. Rev. Fish Dis. 3, 225-240 (1993).
35. Dixon P. In: Recent Developments in Fish Vaccinology. Gudding R, Lillehaung A, Evensen Ø. Vet. Immunol. Immunopathol. 72(1-2), 203-212 (1999).
36. Budowsky EI, Smirnovt YA, Shenderovich SF. Principles of selective inactivation of viral genome. VIII. The influence of B-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11(3), 343-348 (1993).
37. Bachmann MF, Kündig TM, Kalberer CP, Hengartner H, Zinkernagel RM. Formalin inactivation of vesicular stomatitis virus impairs T-cell-but not T-help-independent B-cell responses. J. Virol. 67(7), 3917-3922 (1993).
38. Ferguson M, Wood DJ, Minor PD. Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. (Part 4), 685-690 (1993).
39. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89(4), 405-421 (1969).
40. Nishimura T, Sasaki H, Ushiyama M, et al. A trial of vaccination against rainbow trout fry with formalin killed IHN virus. Fish Pathol. 20(2-3), 435-443 (1985).
41. Amend DF. Prevention and control of viral diseases of salmonids. J. Fish Res. Board Can. 33(4), 1059-1066 (1976).
42. Dorson M. Vaccination trials of rainbow trout fry against infectious pancreatic necrosis. Bull. Off. Int. Epizoot. 87(5-6), 405-406 (1977).
43. Hill BJ, Dorson M, Dixon PF. Studies on immunization of trout against IPN. In: Fish Diseases. Third COMPAQ Sessions. Ahne W (Ed.). Springer-Verlag, Berlin, Germany, 29-36 (1980).
44. Scotland LM, Dobos P, Stevenson RMW. Immunization of adult brook trout, Salvelinus fontinalis (Mitchill), fails to prevent the infectious pancreatic necrosis virus (IPNV) carrier state. J. Fish Dis. 18(5), 449-458 (1995).
45. Nakajima K, Maeno Y, Kurita J, Inui Y. Vaccination against red sea bream iridoviral disease in red sea bream. Fish Pathol. 32(4), 205-209 (1997).
46. Nakajima K, Maeno Y, Honda A, Yokoyama K, Tooriyama T, Manabe S. Effectiveness of a vaccine against red sea bream iridoviral disease in a field trial test. Dis. Aquat. Org. 36(1), 73-75 (1999).
47. Kurita J, Nakajima K. Megalocytiviruses. Viruses 4(4), 521-538 (2012).
48. Pakingking R Jr, Bautista NB, de Jesus-Ayson EG, Reyes O. Protective immunity against viral nervous necrosis (VNN) in brown-marbled grouper (Epinephelus fuscogutattus) following vaccination with inactivated betanodavirus. Fish Shellfish Immunol. 28(4), 525-533 (2010).
49. Sommerset I, Krossøy B, Biering E, Frost P. Vaccines for fish in aquaculture. Expert Rev. Vaccines 4(1), 89-101 (2005).
50. Galligani G, David-Andersen I, Fossum B. Regulatory constraints as seen from the pharmaceutical industry. Dev. Biol. (Basel) 121, 235-241 (2005).
51. Rodriguez Saint-Jean S, Borrego JJ, Perez-Prieto SI. Infectious pancreatic necrosis virus: biology, pathogenesis, and diagnostic methods. Adv. Virus Res. 62, 113-165 (2003).
52. Gilmore RD, Engelking HM, Manning DS, Leong JC. Expression in Escherichia coli of an epitope of the glycoprotein of Infectious hematopoietic necrosis virus protects against viral challenge. Biotechnology 6(3), 295-300 (1988).
53. Lorenzen N, Olesen NJ, Jørgensen PE, Etzerodt M, Holtet TL, Thøgersen HC. Molecular cloning and expression in Escherichia coli of the glycoprotein gene of VHS virus, and immunization of rainbow trout with the recombinant protein. J. Gen. Virol. 74 (Pt 4), 623-630 (1993).
54. Lecocq-Xhonneux F, Thiry M, Dheur I et al. A recombinant viral haemorrhagic septicaemia virus glycoprotein expressed in insect cells induces protective immunity in rainbow trout. J. Gen. Virol. 75 (Pt 7), 1579-1587 (1994).
55. Cain KD, Byrne KM, Brassfield AL, LaPatra SE, Ristow SS. Temperature dependent characteristics of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells. Dis. Aquat. Org. 36(1), 1-10 (1999).
56. Cain KD, LaPatra SE, Shewmaker B, Jones J, Byrne KM, Ristow SS. Immunogenicity of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells. Dis. Aquat. Org. 36(1), 67-72 (1999).
57. Shivappa RB, McAllister PE, Edwards GH, Santi N, Evensen O, Vakharia VN. Development of a subunit vaccine for infectious pancreatic necrosis virus using a baculovirus insect/larvae system. Dev. Biol. (Basel) 121, 165-174 (2005).
58. Martinez-Alonso S, Vakharia VN, Saint-Jean SR, Pérez-Prieto S, Tafalla C. Immune responses elicited in rainbow trout through the administration of infectious pancreatic necrosis virus-like particles. Dev. Comp. Immunol. 36(2), 378-384 (2012).
59. Caswell-Reno P, Reno PW, Nicholson BL. Monoclonal antibodies to infectious pancreatic necrosis virus: analysis of viral epitopes and comparison of different isolates. J. Gen. Virol. 67 (Pt 10), 2193-2205 (1986).
60. Frost P, Håvarstein LS, Lygren B, Ståhl S, Endresen C, Christie KE. Mapping of neutralization epitopes on infectious pancreatic necrosis viruses. J. Gen. Virol. (Pt 5), 1165-1172 (1995).
61. Liu W, Hsu CH, Chang CY, Chen HH, Lin CS. Immune response againts grouper nervous necrosis virus by vaccination of virus-like particles. Vaccine 24(37-39), 6282-6287 (2006).
62. Thiéry R, Cozien J, Cabon J, Lamour F, Baud M, Schneemann A. Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles. J. Virol. 80(20), 10201-10207 (2006).
63. Øvergårda A-C, Patela S, Nøstbakkenb JO, Nerlanda AH. Atlantic halibut (Hippoglossus hippoglossus L.) T-cell and cytokine response after vaccination and challenge with nodavirus. Vaccine doi:10.1016/j. vaccine.2013.01.034 (2013) (Epub ahead of print).
64. Lu L, Xu H, He Y, Li J. Protection of grass carp, Ctenopharyngon idellus (Valenciennes), through oral administration of a subunit vaccine against reovirus. J. Fish Dis. 34(12), 939-942 (2011).
65. Xue R, Liu L, Cao G, et al. Oral vaccination of BacFish-vp6 against grass carp reovirus evoking antibody response in grass carp. Fish Shellfish Immunol. 34(1), 348-355 (2013).
66. Fridholm H, Eliasson L, Everitt E. Immunogenicity properties of authentic and heterologously synthesized structural protein VP2 of infectious pancreatic necrosis virus. Viral Immunol. 20(4), 635-648 (2007).
67. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1), 1465-1468 (1990).
68. Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK, Lewis PJ, Liang X. Novel viral vaccines for livestock. Vet. Immunol. Immunopathol. 54(1-4), 355-363 (1996).
69. Kowalczyk DW, Ertl HC. Immune responses to DNA vaccines. Cell. Mol. Life Sci. 55(5), 751-770 (1999).
70. Lorenzen N, LaPatra SE. DNA vaccines for aquacultured fish. Rev. Off. Int. Epizoot. 24(1), 201-213 (2005).
71. Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev. Vaccines 11(2), 189-209 (2012).
72. Anderson ED, Mourich DV, Fahrenkrug SC, LaPatra S, Shepherd J, Leong JA. Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus. Mol. Marine Biol. Biotechnol. 5(2), 114-122 (1996).
73. Lorenzen N, Olesen NJ. Immunization with viral antigens: viral haemorrhagic septicaemia. Dev. Biol. Stand. 90, 201-209 (1997).
74. Lorenzen N, Lorenzen E, Einer-Jensen K, Heppell J, Wu T, Davis H. Protective immunity to VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination. Fish Shellfish Immunol. 8(4), 261-270 (1998).
75. Kim CH, Johnson MC, Drennan JD, Simon BE, Thomann E, Leong JA. DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish. J. Virol. 74(15), 7048-7054 (2000).
76. LaPatra SE, Corbeil S, Jones GR, et al. Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination. Vaccine 19(28-29), 4011-4019 (2001).
77. Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE. Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens. Dev. Comp. Immunol. 26(2), 173-179 (2002).
78. Sommerset I, Lorenzen E, Lorenzen N, Bleie H, Nerland AH. A DNA vaccine directed against a rainbow trout rhabdovirus induces early protection against a nodavirus challenge in turbot. Vaccine 21(32), 4661-4667 (2003).
79. Einer-Jensen K, Delgado L, Lorenzen E et al. Dual DNA vaccination of rainbow trout (Oncorhynchus mykiss) against two different rhabdoviruses, VHSV and IHNV, induces specific divalent protection. Vaccine 27(8), 1248-1253 (2009).
80. de Las Heras AI, Pérez Prieto SI, Rodríguez Saint-Jean S. In vitro and in vivo immune responses induced by a DNA vaccine encoding the VP2 gene of the infectious pancreatic necrosis virus. Fish Shellfish Immunol. 27(2), 120-129 (2009).
81. de las Heras AI, Rodríguez Saint-Jean S, Pérez-Prieto SI. Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish. Fish Shellfish Immunol. 28(4), 562-570 (2010).
82. Salonius K, Simard N, Harland R, Ulmer JB. The road to licensure of a DNA vaccine. Curr. Opin. Investig. Drugs 8(8), 635-641 (2007).
83. Zhang M, Hu YH, Xiao ZZ, Sun Y, Sun L. Construction and analysis of experimental DNA vaccines against megalocytivirus. Fish Shellfish Immunol. 33(5), 1192-1198 (2012).
84. Smith HA. Regulation and review of DNA vaccine products. Dev. Biol. (Basel) 104, 57-62 (2000).
85. WHO. Guidelines Assuring the Quality of DNA Vaccines, Tech. Rep. Ser. No. 17 (1997).
86. Alonso M, Chiou PP, Leong JA. Development of a suicidal DNA vaccine for infectious hematopoietic necrosis virus (IHNV). Fish Shellfish Immunol. 30(3), 815-823 (2011).
87. Gillund F, Kjølberg KA, von Krauss MK, Myhr AI. Do uncertainty analyses reveal uncertainties? Using the introduction of DNA vaccines to aquaculture as a case. Sci. Total Environ. 407(1), 185-196 (2008).
88. Myhr AI, Dalmo RA. Introduction of genetic engineering in aquaculture; ecological and ethical implications for science and governance. Aquaculture 250(3-4), 542-554 (2005).
89. Carrington AC, Secombes CJ. A review of CpGs and their relevance to aquaculture. Vet. Immunol. Immunopathol. 112(3-4), 87-101 (2006).
90. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32(3), 155-172 (1998).
91. Weeratna RD, McCluskie MJ, Xu Y, Davis HL. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18(17), 1755-1762 (2000).
92. Mutoloki S, Alexandersen S, Evensen Ø. Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines. Fish Shellfish Immunol. 16(5), 633-644 (2004).
93. Koppang EO, Bjerkås I, Haugarvoll E, et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J. Immunol. 181(7), 4807-4814 (2008).
94. Guerrero J, Gattas CR. Immunolomodulating substances: an overview. Rev. Microbiol. 13(2), 110-115 (1982).
95. Wagnerová J, Ferencík M. Secretory and regulatory products of macrophages in the immune and inflammatory reactions. Biol. Bratislav. 48(6), 709-717 (1993).
96. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760 (2002).
97. Tokunaga T, Yamamoto H, Shimada S, et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72(4), 955-962 (1984).
98. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374(6522), 546-549 (1995).
99. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl Acad. Sci. USA 93(7), 2879-2883 (1996).
100. Jørgensen JB, Johansen A, Stenersen B, Sommer AI. CpG oligodeoxynucleotides and plasmid DNA stimulate Atlantic salmon (Salmo salar L.) leucocytes to produce supernatants with antiviral activity. Dev. Comp. Immunol. 25(4), 313-321 (2001).
101. Jørgensen JB, Zou J, Johansen A, Secombes CJ. Immunostimulatory CpG oligodeoxynucleotides stimulate expression of IL-1β and interferon-like cytokines in rainbow trout macrophages via a chloroquine-sensitive mechanism. Fish Shellfish Immunol. 11(8), 673-682 (2001).
102. Oumouna M, Jaso-Friedmann L, Evans DL. Activation of nonspecific cytotoxic cells (NCC) with synthetic oligodeoxynucleotides and bacterial genomic DNA: binding, specificity and identification of unique immunostimulatory motifs. Dev. Comp. Immunol. 26(3), 257-269 (2002).
103. Jørgensen JB, Johansen LH, Steiro K, Johansen A. CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.). J. Virol. 77(21), 11471-11479 (2003).
104. Kibenge FS, Godoy MG, Fast M, Workenhe S, Kibenge MJ. Countermeasures against viral diseases of farmed fish. Antiviral Res. 95(3), 257-281 (2012).
105. Hart S, Wrathmell AB, Harris JE, Grayson TH. Gut immunology in fish: a review. Dev. Comp. Immunol. 12(3), 453-480 (1988).
106. Nasir A. Nanotechnology in vaccine development: a step forward. J. Invest. Dermatol. 129(5), 1055-1059 (2009).
107. NASS-USDA, 2011. Trout production. http://usda01.library.cornell.edu/ usda/nass/TrouProd//2010s/2011/Trou-Prod-02-25-2011-new-format.pdf (Accessed November 2012)
108. NASS-USDA, 2012. Trout production. http://usda01.library.cornell.edu/ usda/current/TrouProd/TrouProd-02-24-2012. pdf (Accessed November 2012)
109. APHIS-USDA, 2008. National Aquatic Animal Health Plan for the United States. www.aphis.usda.gov/animal-health/animal-dis-spec/aquaculture/downloads/ naahp.pdf (Accessed March 2013)
110. OIE, 2013. OIE-listed diseases, infections and infestations in force in 2013. www.oie.int/en/animal-health-in-theworld/oie-listed-diseases-2013/ (Accessed March 2013)
111. European Agency for Evaluation of Medical Products, Committee for Veterinary Medical Products (2001). Note for guidance: DNA vaccines non-applicable in eukaryotic cells for veterinary use. www.emea.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2009/10/WC500004614.pdf (Accessed July 2012)
112. Guidance for Industry. Considerations for plasmid DNA vaccines for infectious disease indications (2007). www.fda.gov/downloads/BiologicsBlood- Vaccines/GuidanceComplianceRegulatory-Information/Guidances/Vaccines/ucm091968. pdf (Accessed January 2012)
113. General principles for the development of vaccines to protect against global infectious diseases (2011). www.fda.gov/downloads/BiologicsBlood- Vaccines/GuidanceComplianceRegulatory-Information/Guidances/Vaccines/UCM282995. pdf (Accessed January 2012)
114. Points to consider on plasmid DNA vaccines for preventive infectious disease indications. Guidance for industry. Considerations for plasmid DNA vaccines for infectious disease indications (1996). www.seoho.biz/GMP-Quick- Search/Data/1.%20FDA%20Documents/1.3.149.pdf (Accessed June 2012)